The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Arthroplasty, Replacement, Knee

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Arthroplasty, Replacement, Knee


High impact information on Arthroplasty, Replacement, Knee


Chemical compound and disease context of Arthroplasty, Replacement, Knee


Biological context of Arthroplasty, Replacement, Knee


Anatomical context of Arthroplasty, Replacement, Knee


Associations of Arthroplasty, Replacement, Knee with chemical compounds


Gene context of Arthroplasty, Replacement, Knee


Analytical, diagnostic and therapeutic context of Arthroplasty, Replacement, Knee


  1. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. Heit, J.A., Colwell, C.W., Francis, C.W., Ginsberg, J.S., Berkowitz, S.D., Whipple, J., Peters, G. Arch. Intern. Med. (2001) [Pubmed]
  2. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement. Francis, C.W., Pellegrini, V.D., Leibert, K.M., Totterman, S., Azodo, M.V., Harris, C.M., Cox, C., Marder, V.J. Thromb. Haemost. (1996) [Pubmed]
  3. Abnormal extracellular matrix metabolism in chronically ischemic skin: a mechanism for dermal failure in leg ulcers. Dalton, S.J., Mitchell, D.C., Whiting, C.V., Tarlton, J.F. J. Invest. Dermatol. (2005) [Pubmed]
  4. Effects of reducing physical therapy services on outcomes in total joint arthroplasty. Liang, M.H., Cullen, K.E., Larson, M.G., Schwartz, J.A., Robb-Nicholson, C., Fossel, A.H., Roberge, N., Poss, R. Medical care. (1987) [Pubmed]
  5. Effect of oral and i.v. tenoxicam in postoperative pain after total knee replacement. Eggers, K.A., Jenkins, B.J., Power, I. British journal of anaesthesia. (1999) [Pubmed]
  6. Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Eriksson, B.I., Bergqvist, D., Kälebo, P., Dahl, O.E., Lindbratt, S., Bylock, A., Frison, L., Eriksson, U.G., Welin, L., Gustafsson, D. Lancet (2002) [Pubmed]
  7. Enhanced in-vivo platelet release reaction, increased thromboxane synthesis, and decreased prostacyclin release after tourniquet ischaemia. Zahavi, J., Price, A.J., Westwick, J., Scully, M.F., Al-Hasani, S.F., Honey, A.C., Dubiel, M., Kakkar, V.V. Lancet (1980) [Pubmed]
  8. Evidence for a key role of leptin in osteoarthritis. Dumond, H., Presle, N., Terlain, B., Mainard, D., Loeuille, D., Netter, P., Pottie, P. Arthritis Rheum. (2003) [Pubmed]
  9. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. Ziolkowska, M., Kurowska, M., Radzikowska, A., Luszczykiewicz, G., Wiland, P., Dziewczopolski, W., Filipowicz-Sosnowska, A., Pazdur, J., Szechinski, J., Kowalczewski, J., Rell-Bakalarska, M., Maslinski, W. Arthritis Rheum. (2002) [Pubmed]
  10. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Kotake, S., Udagawa, N., Hakoda, M., Mogi, M., Yano, K., Tsuda, E., Takahashi, K., Furuya, T., Ishiyama, S., Kim, K.J., Saito, S., Nishikawa, T., Takahashi, N., Togari, A., Tomatsu, T., Suda, T., Kamatani, N. Arthritis Rheum. (2001) [Pubmed]
  11. Intra-articular morphine and/or bupivacaine after total knee replacement. Ritter, M.A., Koehler, M., Keating, E.M., Faris, P.M., Meding, J.B. The Journal of bone and joint surgery. British volume. (1999) [Pubmed]
  12. Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies. Eriksson, B.I., Ogren, M., Eriksson, U.G., Kälebo, P., Ahnfelt, L., Björkström, S., Sjöstedt, A., Folestad, A., Arfwidsson, A.C., Elvander, C.S., Frison, L. Thromb. Res. (2002) [Pubmed]
  13. The Genesis total knee prosthesis: a 10-year followup study. Laskin, R.S. Clin. Orthop. Relat. Res. (2001) [Pubmed]
  14. Cost-effectiveness analysis of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting. Chang, P., Okamoto, M., Chen, J., Frame, D. Journal of managed care pharmacy : JMCP. (2005) [Pubmed]
  15. Effects of dexamethasone in preventing postoperative emetic symptoms after total knee replacement surgery: a prospective, randomized, double-blind, vehicle-controlled trial in adult Japanese patients. Fujii, Y., Nakayama, M. Clinical therapeutics. (2005) [Pubmed]
  16. Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis. Escalante, A., Beardmore, T.D. J. Rheumatol. (1995) [Pubmed]
  17. Minimally invasive total knee replacement through a mini midvastus approach: a comparative study. Haas, S.B., Cook, S., Beksac, B. Clin. Orthop. Relat. Res. (2004) [Pubmed]
  18. Continuous low-dose 3-in-1 nerve blockade for postoperative pain relief after total knee replacement. Edwards, N.D., Wright, E.M. Anesth. Analg. (1992) [Pubmed]
  19. The Insall Award. Total knee replacement with posterior cruciate ligament retention in rheumatoid arthritis. Problems and complications. Laskin, R.S., O'Flynn, H.M. Clin. Orthop. Relat. Res. (1997) [Pubmed]
  20. Total knee replacement: a comparison of ropivacaine and bupivacaine in combined femoral and sciatic block. McNamee, D.A., Convery, P.N., Milligan, K.R. Acta anaesthesiologica Scandinavica. (2001) [Pubmed]
  21. The patella in total knee replacement: does it matter? 750 LCS total knee replacements without resurfacing of the patella. Müller, W., Wirz, D. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA. (2001) [Pubmed]
  22. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Rosen, G., Murphy, M.L., Huvos, A.G., Gutierrez, M., Marcove, R.C. Cancer (1976) [Pubmed]
  23. Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement. Francis, C.W., Pellegrini, V.D., Harris, C.M., Marder, V.J. Am. J. Med. (1989) [Pubmed]
  24. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a randomized, double-blind, comparative trial. Chen, J.J., Frame, D.G., White, T.J. Arch. Intern. Med. (1998) [Pubmed]
  25. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery. Eriksson, B.I., Arfwidsson, A.C., Frison, L., Eriksson, U.G., Bylock, A., Kälebo, P., Fager, G., Gustafsson, D. Thromb. Haemost. (2002) [Pubmed]
  26. A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report. Wall, R., Klenerman, L., McCullough, C., Fyfe, I. J. Antimicrob. Chemother. (1988) [Pubmed]
  27. Stimulation of human synovial cell DNA synthesis by iron. Nishiya, K. J. Rheumatol. (1994) [Pubmed]
  28. Treatment and clinical management of recurrent knee empyema due to methicillin-resistant Staphylococcus aureus (MRSA) after total knee replacement. Kapella, M., Kampf, G., Holzheimer-Stock, C., Kreusch-Brinker, R. Archives of orthopaedic and trauma surgery. (2001) [Pubmed]
  29. Long-term followup after mobile-bearing total knee replacement. Buechel, F.F. Clin. Orthop. Relat. Res. (2002) [Pubmed]
  30. Posterior cruciate ligament at total knee replacement. Essential, beneficial or a hindrance? Straw, R., Kulkarni, S., Attfield, S., Wilton, T.J. The Journal of bone and joint surgery. British volume. (2003) [Pubmed]
  31. C-reactive protein level after total hip and total knee replacement. White, J., Kelly, M., Dunsmuir, R. The Journal of bone and joint surgery. British volume. (1998) [Pubmed]
  32. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group. Heit, J.A., Berkowitz, S.D., Bona, R., Cabanas, V., Corson, J.D., Elliott, C.G., Lyons, R. Thromb. Haemost. (1997) [Pubmed]
  33. Clinical experience with ximelagatran in orthopaedic surgery. Eriksson, B. Drugs (2004) [Pubmed]
  34. Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplasty. Hoddinott, C., Lovering, A.M., Fernando, H.C., Dixon, J.H., Reeves, D.S. J. Antimicrob. Chemother. (1990) [Pubmed]
  35. Pentasaccharide Org31540/SR90107A clinical trials update: lessons for practice. Turpie, A.G. Am. Heart J. (2001) [Pubmed]
  36. Ineffective analgesia after extradural tramadol hydrochloride in patients undergoing total knee replacement. Grace, D., Fee, J.P. Anaesthesia. (1995) [Pubmed]
WikiGenes - Universities